 
        
        
      
    
    Mitigating Antimalarial Resistance Consortium in South-East Africa
Photo: Arne Hoel / World Bank
The MARC SE-Africa consortium aims to better define the extent of antimalarial resistance in SE-Africa and to expedite the sharing of such evidence with National Malaria Programmes and their implementation partners.
Our goal is to protect the efficacy of current first-line malaria treatments, which can help prevent thousands of additional malaria deaths annually.
Are you worried about antimalarial drug resistance?
We are here to help you tackle drug-resistant malaria in our region. Our team is working on:
Network, Landscape and Gap Analysis
Objectives: Find the gaps
Addressing Key Evidence Gaps
Objectives: Fill the gaps
Detailed Action Plan to Respond to Antimalarial Resistance
Objectives: Plan the way forward
Implementation into Policy and Practice
Objectives: Make it all happen (and check if it works)
Project Management, Communication and Dissemination
Objectives: Support the consortium, explain the project, make its results widely known
We can provide technical support to your country.
We can help with:
- developing a costed regional action plan to respond promptly to emerging antimalarial drug resistance 
- updating and disseminating malaria treatment guidelines 
- ensuring you are part of the fight against antimalarial drug resistance 
If you are interested in working with us, get in touch.
Prof Karen I Barnes
University of Cape Town (UCT) Collaborating Centre for Optimising Antimalarial Therapy (CCOAT)
Email: marcseafrica@uct.ac.za
 
                         
              
              
             
              
              
             
              
              
             
              
              
             
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
              